论文部分内容阅读
目的:研究免疫疗法对肺结核治疗的临床疗效。方法:将2014年10月至2016年10月接受治疗的肺结核患者75例随机分为对照组(37例)和观察组(38例)。对照组患者使用左氧氟沙星、利福喷丁、力克肺疾等常规药物治疗;观察组患者在对照组的基础上,增加胸腺肽免疫治疗。治疗2个疗程以后检测对照组和观察组的临床症状、痰菌变化值、胸部CT变化的结果。结论:免疫疗法的治疗效果比常规治疗的效果要好,在治疗肺结核的过程中应该采用免疫疗法和常规疗法结合的方法进行治疗。
Objective: To study the clinical effect of immunotherapy on tuberculosis. Methods: Seventy-five patients with tuberculosis who were treated from October 2014 to October 2016 were randomly divided into control group (37 cases) and observation group (38 cases). Patients in the control group were treated with conventional drugs such as levofloxacin, rifapentine, Lectra pulmonary disease, etc. Patients in the observation group were given thymosin immunotherapy on the basis of the control group. After 2 courses of treatment, the clinical symptoms, the changes of sputum bacteria and the changes of chest CT were detected in the control group and the observation group. Conclusion: Immunotherapy has a better therapeutic effect than conventional treatment. In the treatment of pulmonary tuberculosis, immunotherapy should be used in combination with conventional therapy.